相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity
Rens de Groot et al.
BLOOD (2010)
First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours
Clemens Unger et al.
EUROPEAN JOURNAL OF CANCER (2010)
The NF-kappa B activation pathways, emerging molecular targets for cancer prevention and therapy
Yong Lin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Perifosine: Update on a Novel Akt Inhibitor
Joell J. Gills et al.
CURRENT ONCOLOGY REPORTS (2009)
Targeting NF-κB in Waldenstrom macroglobulinemia
Xavier Leleu et al.
BLOOD (2008)
Extended follow-up of a phase 3 trial in relapsed multiple myeloma:: final time-to-event results of the APEX trial
Paul G. Richardson et al.
BLOOD (2007)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: Results of WMCTG trial 03-248
Steven P. Treon et al.
CLINICAL CANCER RESEARCH (2007)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BLOOD (2006)
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid
SR Vink et al.
INVESTIGATIONAL NEW DRUGS (2005)
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
C Nakanishi et al.
NATURE REVIEWS CANCER (2005)
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
M Rahmani et al.
CANCER RESEARCH (2005)
Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer
R Voboril et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Advances in biology of multiple myeloma: clinical applications
T Hideshima et al.
BLOOD (2004)
A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer
L Van Ummersen et al.
CLINICAL CANCER RESEARCH (2004)
Novel therapeutic approaches for multiple myeloma
T Hideshima et al.
IMMUNOLOGICAL REVIEWS (2003)
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
T Hideshima et al.
BLOOD (2003)
Molecular mechanisms of novel therapeutic approaches for multiple myeloma
T Hideshima et al.
NATURE REVIEWS CANCER (2002)
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours
M Crul et al.
EUROPEAN JOURNAL OF CANCER (2002)
分享论文
